Articles
12 months on: REVA presents stent trial follow-up results
Twelve-month, follow-up data from the first eight patients enrolled in a trial of REVA Medical’s (ASX:RVA) bioresorbable coronary stent supports the safety of the product. [ + ]
NASA is looking for far-out ideas
NASA is looking for ideas that it can use to transform future aerospace missions, enable new capabilities or significantly alter current approaches to launching, building and operating aerospace systems - and it is offering $500,000 over two years to further analyse and develop the innovative concepts. [ + ]
Alchemia teams with Merck Serono for cancer trial
Alchemia (ASX:ACL) has announced a collaborative trial of HA-Irinotecan with Merck Serono’s Erbitux and blamed seasonal factors for falling quarterly fondaparinux sales. [ + ]
Resistance to computation is futile
Associate Professor Andrew Lonie outlines the importance of bioinformatics to today’s research labs and showcases one researcher who talks about how it has changed the way she works. [ + ]
Don’t breathe your way to worse cholesterol
Academic researchers have found that breathing motor vehicle emissions triggers a change in high-density lipoprotein (HDL) cholesterol, altering its cardiovascular protective qualities so that it actually contributes to clogged arteries. [ + ]
Depressed brains out of sync with the world
The brain acts as a timekeeper for each cell’s 24-hour body clock, keeping this clock in sync with the world so that it can govern our appetites, sleep, moods and more. But new research shows that the clock may be broken in the brain cells of people with depression, meaning they operate out of sync with the usual ingrained daily cycle. [ + ]
Federal Budget fallout
The 2013 Federal Budget has come down with cuts and pardons spread across the board for science, research, industry and education. [ + ]
10 commandments for next-gen sequencing
Geneticist Dan Koboldt from the Genome Institute at Washington University in St Louis gives his decalogue on next-generation sequencing. [ + ]
Phosphagenics and US agency target cow infection
Phosphagenics (ASX:POH) and a US Department of Agriculture research agency will jointly formulate and test products aimed at fighting the bacterial infection mastitis in dairy cows. [ + ]
AusBiotech secures Australian first with world brain mapping congress
AusBiotech is pleased to announce that the 11th Annual World Congress of the Society for Brain Mapping and Therapeutics (SBMT) will be held in Australia for the first time in March 2014. [ + ]
Worm your way out of obesity
Researchers have shown in a mouse model that infection with roundworms (nematodes) can not only combat obesity but ameliorate related metabolic disorders. [ + ]
Starpharma dendrimer effective against adenovius
Starpharma (ASX:SPL) said its lead dendrimer candidate has shown potential as the first treatment for adenovirus, the primary cause of viral conjunctivitis. [ + ]
Somatosensory feedback and prostheses
Neurobiologists have reproduced a sense of touch - showing how an organism can sense a tactile stimulus, in real time, through an artificial sensor in a prosthetic hand. [ + ]
Bioniche in talks to boost cash reserves
Bioniche (ASX:BNC) is in talks with its lender to address a looming cash shortage and consulting with advisers to address the “challenges” posed by a group of dissident shareholders. [ + ]
Philanthropy, advocacy and vision
Four public organisations have joined forces to take an international approach in health and medical research advocacy. [ + ]